Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Omega-3
Selected research topic
Migraine and pain
The comparison is unconfirmed, so the findings cannot establish this ingredient’s effect.
- Publications for this topic
- 1
- Human comparison publications
- 0
- Publications needing review
- 0
Findings in the studies
duration of migraine attacks
Publications linked to this measurement: 1
Review of existing studies · population needs confirmation
- A result was reported, but the comparison could not be confirmed.varied across included trials
Measurement and study conditions
- Study type
- Systematic review
- Study population
- Recorded population category: Patient group. Whether the research involved humans needs confirmation.
- Ingredients tested
- Unknown intervention
- How results were compared
- Study comparison: pooled meta-analysis result; abstract does not identify trial comparators in this result sentence
- Measurement time
- varied across included trials
frequency
Publications linked to this measurement: 1
Review of existing studies · population needs confirmation
- A result was reported, but the comparison could not be confirmed.varied across included trials
Measurement and study conditions
- Study type
- Systematic review
- Study population
- Recorded population category: Patient group. Whether the research involved humans needs confirmation.
- Ingredients tested
- Unknown intervention
- How results were compared
- Study comparison: pooled meta-analysis result; abstract does not identify trial comparators in this result sentence
- Measurement time
- varied across included trials
severity
Publications linked to this measurement: 1
Review of existing studies · population needs confirmation
- A result was reported, but the comparison could not be confirmed.varied across included trials
Measurement and study conditions
- Study type
- Systematic review
- Study population
- Recorded population category: Patient group. Whether the research involved humans needs confirmation.
- Ingredients tested
- Unknown intervention
- How results were compared
- Study comparison: pooled meta-analysis result; abstract does not identify trial comparators in this result sentence
- Measurement time
- varied across included trials
Representative outcome and study details
Studies with an unspecified organism reported a result with no confirmed comparison group in duration of migraine attacks.
Scope not specified · Includes patient groups · comparator not confirmed
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: C
The 50.0 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of the evidence centers on contextual or measured outcomes rather than general-use effects, limited repetition across independent human clinical studies.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 115
Papers linked to this topic 1 · distinct papers 1 · comparison findings need further review · papers needing additional review 0
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- duration of migraine attacks: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- frequency: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- severity: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
duration of migraine attacks
A result was reported, but the comparison could not be confirmed.
Review · Unknown intervention · Patient group
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
frequency
A result was reported, but the comparison could not be confirmed.
Review · Unknown intervention · Patient group
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
severity
A result was reported, but the comparison could not be confirmed.
Review · Unknown intervention · Patient group
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No combination cautions are available to show in the current data. This does not guarantee safety.
Review 2 combination findings and 0 findings that outperformed an ingredient alone.
Reported improvements with combinations
Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.
Combinations with reported improvement
The combination showed improvement, but each ingredient's contribution is unclear.
비타민 DCombined vitamin D and omega-3 fatty acids showed a 31% reduction in autoimmune disease incidence compared to placebo, suggesting a potential additive effect.
알파리포산The combination of omega-3 fatty acids and alpha-lipoic acid showed significant benefits in slowing cognitive and functional decline compared to placebo or omega-3 alone.